Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

ARA-290: Innate Repair Receptor Research

ARA-290 (also known as cibinetide) is an 11-amino acid peptide derived from the beta common receptor (βcR) binding domain of erythropoietin (EPO). It was designed to activate the innate repair receptor (IRR), a heteromer of the EPO receptor and βcR, without the erythropoietic activity of full-length EPO.

Innate Repair Receptor

The IRR is a tissue-protective receptor complex distinct from the classical erythropoietic EPO receptor. When activated by ARA-290, it triggers anti-inflammatory and tissue-protective signaling cascades including the JAK2/STAT5 and PI3K/Akt pathways.

Separation of Activities

By targeting only the IRR and not the homodimeric EPO receptor responsible for erythropoiesis, ARA-290 provides cytoprotective effects without increasing red blood cell production. This selectivity is achieved through the peptide’s mimicry of the specific EPO helix that contacts the βcR subunit.